Towards a Better Definition of Therapeutic Concepts in Atopic Dermatitis: Learning from Rheumatoid Arthritis Dear Colleagues, Dear Friends, Since the 1980s, rheumatoid arthritis (RA) has served as a model for therapeutic strategies in chronic inflammatory diseases. RA activity is assessed using multiple measures, including swollen joint counts, inflammatory markers, and radiographic signs of joint damage. […]
Read More
Defining a good indication of nemoluzimab based on clinical criteria➜ DOI: 10.1111/1346-8138.17626Nemolizumab is an effective treatment for pruritus in atopic dermatitis, but it has a relatively high incidence of cutaneous adverse events (cAEs). To optimize the use of nemolizumab, Japanese researchers investigated the relationship between baseline severity in specific body areas and the frequency of cAEs. [...] Read More
AI in AD and Allergy Research: Enhancing Collaboration with AI Experts Dear Colleagues, Dear Friends, Advances in AI over the past two years have significantly transformed the medical landscape, challenging vigorously our professional environment. A thorough review by Lisik et al. [link] provides an insightful overview of AI’s applications in AD and allergy research—a field […]
Read More
Season of birth shapes human milk microbiome➜ DOI: 10.1111/all.16469In this Australian study, the season of infant birth emerged as the strongest determinant of the microbiome community structure with impacts on five of the most abundant taxa. This seasonal effect is not correlated with a bad taxon more prevalent in winter where AD is more common. The [...] Read More
Communication from GADA Kicking off the new year with exciting news! We’re thrilled to announce the upcoming launch of the ISAD-GADA Fellowship! This program is designed to support #earlycareer #dermatologists or researchers in #epidemiology and #publichealth, providing them with the opportunity to collaborate with the GADA team, acquire valuable skills, and lead a small GADA […]
Read More
#event #free #online Save the date: April 4th, 2025 15:00-17:00 CEST Misinformation has been recognized as a critical Global Health challenge during the COVID pandemic, prompting its inclusion on the World Health Organization’s (WHO) priority list. In the digital age, the rapid spread of health-related misinformation on social media poses a significant threat to public […]
Read More
Buzzes and controversies of last year in the AD literature Dear Colleagues, Dear Friends, On behalf of ISAD, I extend my best wishes for a bright and successful New Year, filled with new achievements that will benefit our patients. We are actively planning our 2025 meetings and are excited to share some updates. Our Spring […]
Read More
Better spatial tissue imaging techniques to differentiate CTCL and AD➜ DOI: 10.1038/s41540-024-00474-xCutaneous T-cell lymphomas (CTCLs) can be difficult to distinguish from inflammatory skin conditions like atopic dermatitis (AD). Multi-antigen imaging protein abundance maps were analyzed with spatial graphs inferred from the cells' positions in the tissue samples. Characteristic patterns of skin tissue organization allowed a high-precision [...] Read More
ATOPIC DERMATITIS with focus on Sub-Saharan Africa Training for national and district-level health workers We are happy to inform you that the 6-module training course on AD including videos is now available on OpenWHO in Spanish!
Read More
AD evidence-based medicine outcome instruments: how to better integrate patients’ preferences? Dear Colleagues, Dear Friends, A recently published study funded by Galderma investigates with the quantitative method named discrete choice experiment (DCE) the preference of patients and physicians when prescribing systemic treatments for AD. This DCE method is increasingly used in healthcare to elicit preferences […]
Read More